Key Industry Expert Speakers
9th RWE, Market Access, Pricing & Reimbursement Global Congress 2023 Europe
Trends and Strategies to Achieve Optimum Patient Access to Healthcare
4th - 5th May 2023 - Copthorne Tara Hotel London Kensington, London, UK
- Dr. Marco Rauland, Vice President, Global Value Demonstration, Market Access & Pricing, Merck KGaA
- Daniel Jackson, Global Head - Market Access Policy, UCB
- Silvy Mardiguian, Market Access Director, UK & Ireland, BeiGene UK
- Ana Plata, Global Pricing Head - BioPharmaceuticals, AstraZeneca
- Santoke Naal, Director Market Access, IGES U.K. Pharma Ltd
- Libby Hamson, Senior Manager, Market Access, Pfizer
- Elvira Müller, Vice President, Evidence & Access, CERTARA
- Claudia Neuber, Head of Global Pricing Implementation Oncology, AstraZeneca
- Maria Danchenko, Global Market Access Academy Lead, Sanofi
- Eugean Jiwanmall, Sr Research Analyst, Independence Blue Cross
- Laura Clark-Kelly, Sr Director, US Market Access Strategy, Women's Health, Bayer
- Maarten Van Baelen, Executive Director, Plasma Protein Therapeutics Association
- Matthias Heck, Sr Director, International TA Policy Strategy, Alexion Pharmaceuticals
- Gomathi Kaliappan, Global Pricing & Reimbursement Leader, Roche
- Ilona Torontali, Global Head of Pricing & Reimbursement, Roche
- Vasiliki Patsioura, Global Pricing Implementation Lead, Astrazeneca*
- Esther Nzenza, Founder and CEO, Decisive Consulting Ltd.
- Maria Merinova, Global Pricing & Market Access Senior Team Leader, Almirall*
- Josie Godfrey, Co-Founder and CEO, Realise Advocacy
- Ryotaro Ishikawa, Global Market Access Director, Novartis
- Antje Emmermann, Executive Director, Market Access Lead, Alexion
- Riad Dirani, VP of Global HEOR, Medical Operations & Excellence, Teva
- Rafael Souza, Head, Access Solutions & Pricing, New Markets, BeiGene Switzerland
- Stephane Read, Sr Technical Consultant, Epidemiology, Certara Evidence & Access
- Josie Godfrey, Co-Founder and CEO, Realise Advocacy
- Mitun Patel, Director, Red Nucleus
- Higia Vassoler, Director, Red Nucleus
- Meni Styliadou, VP Global Program Leader – Health Data Partnerships, Data Science Institute. Takeda R&D
- Omar Ali, Visiting Lecturer Value Based Pricing & Innovative Contracting of New Medicines, University of Portsmouth
- Frankie Shupo, Global Director, Market Access and HEOR, EUSA Pharma
- And Much More...

Marco Rauland
Vice President Global Market Access & Pricing - Strategic Planning

DANIEL JACKSON
Global Head - Market Access Policy

Ana Plata
Global Pricing Head - BioPharmaceuticals

Rafael Souza, Ph.D
Head of Access Solutions & Pricing, New Markets

Riad Dirani
VP, Global HEOR, Medical Operations & Excellence

CLAUDIA NEUBER
Head, Global Pricing Oncology, Global Market Access & Pricing

SILVY MARDIGUIAN
Market Access Director, UK & Ireland

Elvira Müller
Vice President

Ryotaro Ishikawa
Global Market Access Director

Maria Danchenko
Global Market Access Academy Lead

LAURA A CLARK-KELLY
Sr. Director

Maarten Van Baelen
Executive Director

Vasiliki Patsioura
Global Pricing Implementation Lead

SANTOKE NAAL
Director Market Access

Matthias Heck
Attorney-at-law, Senior Director, International TA Policy Strategy
Alexion AstraZeneca Rare Disease

Matthias Heck
Attorney-at-law, Senior Director, International TA Policy Strategy

Mitun Patel
Director

Higia Vassoler
Associate Director

Josie Godfrey
Co-Founder and CEO, Realise Advocacy, Director

Stephane Read
Senior Technical Consultant in Epidemiology

Esther Nzenza
Founder and CEO

Meni Styliadou
VP Global Program Leader – Health Data Partnerships, Data Science Institute.
Takeda R&D

Meni Styliadou
VP Global Program Leader – Health Data Partnerships, Data Science Institute.

Frankie Shupo
Global Director, Market Access and HEOR

Omar Ali
Visiting Lecturer Value Based Pricing & Innovative Contracting of New Medicines
University of Portsmouth

Omar Ali
Visiting Lecturer Value Based Pricing & Innovative Contracting of New Medicines

DR MEHDI JAVANBAKHT
Director